FDA Approved Products

4,498 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LOE ApproachingClear all
SABRIL
vigabatrin
LOE Approaching
Lundbeck
ORAL · FOR SOLUTION
2009
NDA
30/100
SABRIL
vigabatrin
LOE Approaching
Lundbeck
ORAL · TABLET
2009
NDA
30/100
SALAGEN
pilocarpine hydrochloride
LOE Approaching
ORAL · TABLET
1994
NDA
30/100
SALPIX
acetrizoate sodium
LOE Approaching
Johnson & Johnson
INTRAUTERINE · SOLUTION
1953
NDA
30/100
SALURON
hydroflumethiazide
LOE Approaching
Takeda
ORAL · TABLET
1959
NDA
30/100
SALUTENSIN
hydroflumethiazide; reserpine
LOE Approaching
Takeda
ORAL · TABLET
1960
NDA
30/100
SALUTENSIN-DEMI
hydroflumethiazide; reserpine
LOE Approaching
Takeda
ORAL · TABLET
1960
NDA
30/100
SANCTURA
trospium chloride
LOE Approaching
AbbVie
ORAL · TABLET
2004
NDA
30/100
SANCTURA XR
trospium chloride
LOE Approaching
AbbVie
ORAL · CAPSULE, EXTENDED RELEASE
2007
NDA
30/100
SANCUSO
granisetron
LOE Approaching
Cumberland Pharmaceuticals
TRANSDERMAL · FILM, EXTENDED RELEASE
2008
NDA
30/100
SANDIMMUNE
cyclosporine
LOE Approaching
Novartis
INJECTION · INJECTABLE
1983
NDA
30/100
SANDIMMUNE
cyclosporine
LOE Approaching
Novartis
ORAL · CAPSULE
1990
NDA
30/100
SANDIMMUNE
cyclosporine
LOE Approaching
Novartis
ORAL · SOLUTION
1983
NDA
30/100
SANDOSTATIN
octreotide acetate
LOE Approaching
Novartis
INJECTION · INJECTABLE
severe diarrheaflushing episodes associated with metastatic carcinoid tumors+3
1988
PeptideNDA
30/100
SANDOSTATIN LAR
octreotide acetate
LOE Approaching
Novartis
INJECTION · INJECTABLE
tolerated
1998
PeptideNDA
30/100
SANOREX
mazindol
LOE Approaching
Novartis
ORAL · TABLET
1973
NDA
30/100
SANSERT
methysergide maleate
LOE Approaching
Novartis
ORAL · TABLET
1962
NDA
30/100
SARAFEM
fluoxetine hydrochloride
LOE Approaching
ORAL · TABLET
2006
NDA
30/100
SARAFEM
fluoxetine hydrochloride
LOE Approaching
Eli Lilly and Company
ORAL · CAPSULE
1987
NDA
30/100
SCLEROSOL
talc
LOE Approaching
INTRAPLEURAL · AEROSOL
1997
NDA
30/100
SCRUBTEAM SURGICAL SPONGEBRUSH
hexachlorophene
LOE Approaching
TOPICAL · SPONGE
1977
NDA
30/100
SEASONALE
levonorgestrel / ethinyl estradiol
LOE Approaching
Teva
ORAL · TABLET
2003
NDA
30/100
SECONAL SODIUM
secobarbital sodium
LOE Approaching
Eli Lilly and Company
INJECTION · INJECTABLE
1950
NDA
30/100
SECREFLO
secretin synthetic porcine
LOE Approaching
INTRAVENOUS · FOR SOLUTION
2002
NDA
30/100
← PreviousPage 141 of 188Next →